Tivic Subsidiary Velocity Bioworks Signs San Antonio Facility Leases

Reuters03-14 05:28
Tivic Subsidiary Velocity Bioworks Signs San Antonio Facility Leases

Tivic Health Systems Inc.’s wholly owned subsidiary Velocity Bioworks, Inc. entered into three facility agreements in San Antonio, Texas. Velocity Bioworks signed an eight-year lease for an 8,024-square-foot microbial facility with an option to extend and an option to purchase the property for $12.5 million within the first 24 months, a 102-month lease for a 20,144-square-foot mammalian facility, and a 110-month sublease for 8,122 square feet of office space that will serve as Tivic’s new principal executive office.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tivic Health Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-001781), on March 13, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment